Opinion|Videos|July 16, 2024

Managing Evaporative Dry Eye with New FDA-Approved Therapy

Author(s)Jessilin Quint, OD, MBA, MS, FAAO, Selina R. McGee, OD, FAAO, Dipl ABO

Experts provide clinical insights on the first FDA-approved treatment for evaporative dry eye, perfluorohexyloctane ophthalmic solution (MEIBO).

Episodes in this series

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 1 Overview of MGD and Its Causes

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 2 Differentiating Aqueous vs Evaporative Dry Eye

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 3 Long-Term Consequences of Untreated MGD

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 4 Factors to Consider in Treatment Selection for MGD

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 5 Managing Evaporative Dry Eye with New FDA-Approved Therapy

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 6 Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO

EP. 7 Combining In-Office and At-Home Therapies

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO

EP. 8 Clinical Case Scenario: Management Strategies for MGD and Key Takeaways

Video content above is prompted by the following questions:

We now have the first FDA-approved treatment for evaporative dry eye [perfluorohexyloctane ophthalmic solution (MIEBO)]. What is significant about this new treatment?
- Why do we need to target evaporative dry eye specifically?

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related to this article

From Paper to Clinic, Episode 8: Dynamic Muscle Stimulation and the Blink Physiology Behind Dry Eye

October 5th, 2026

From Paper to Clinic, Episode 8: Dynamic muscle stimulation and the blink physiology behind dry eye

Host Hamza Shah, OD, MS, FAAO, is joined by Cory Lappin, OD, MS, FAAO, to discuss dynamic muscle stimulation for dry eye, spurred by a paper on improving blinking in dry eye patients.

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Takeaways from this week in optometry: October 16-23

BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial

Brepocitinib for noninfectious uveitis meets all phase 3 trial end points

More than monitoring: Using AMD visits to promote healthy vision aging

The Independent Advantage S02 E07: Is your front desk missing opportunities?